About
Our Science
Pipeline
Scp776
Acute Ischemic Stroke
ARPEGGIO
News
Contact
News about Silver Creek Pharma
See What We've Been Up To
Featured News
February 12, 2024
Silver Creek Pharmaceuticals Appoints Mark Corrigan, M.D. As President
Read More
Featured Publication
February 12, 2024
Silver Creek Pharmaceuticals Appoints Mark Corrigan, M.D. As President
Read More
All Articles
and Publications
News
Feb 12, 2024
Silver Creek Pharmaceuticals Appoints Mark Corrigan, M.D. As President
Read More
News
Feb 12, 2024
Silver Creek Pharmaceuticals Appoints Mark Corrigan, M.D. As President
Read More
News
Feb 10, 2023
Silver Creek Presents ARPEGGIO, a Phase 2 Clinical Trial Evaluating Scp776 — a First-in-Class Cell Rescue Drug — for the Treatment of Acute Ischemic Stroke
Read More
News
Feb 10, 2023
Silver Creek Presents ARPEGGIO, a Phase 2 Clinical Trial Evaluating Scp776 — a First-in-Class Cell Rescue Drug — for the Treatment of Acute Ischemic Stroke
Read More
Publication
Feb 1, 2023
International Stroke Conference 2023: ARPEGGIO Study Design
Read More
Publication
Feb 1, 2023
International Stroke Conference 2023: ARPEGGIO Study Design
Read More
Publication
Feb 1, 2023
World Stroke Conference 2023: Implementation of a Blood Glucose Management Plan for Scp776
Read More
Publication
Feb 1, 2023
World Stroke Conference 2023: Implementation of a Blood Glucose Management Plan for Scp776
Read More
